A Nandi
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Cancer Treatment and Pharmacology
Papers in
-
- Multiple Myeloma Research and Treatments 4
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
- Oncology 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Timothy PerrenRichard J. OsborneRaymond PowlesPeter J. SelbyJ. S. MalpasM L SlevinC R TillyerGarry Forgeson
- Journals
- British Journal of Haematology (2 papers)British Journal of Cancer (1 paper)The Lancet (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Hematological Oncology (1 paper)
- Partner nations
- United KingdomIndia
In The Last Decade
A Nandi
11 papers receiving 384 citations
Peers
Comparison fields: 5 of 38
- Hematology 321
- Oncology 169
- Genetics 47
- Pathology and Forensic Medicine 49
- Molecular Biology 157
Countries citing papers authored by A Nandi
This map shows the geographic impact of A Nandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Nandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Nandi more than expected).
Fields of papers citing papers by A Nandi
This network shows the impact of papers produced by A Nandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Nandi. The network helps show where A Nandi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Nandi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 1 | |
| 2 | 1997 | 6 | |
| 3 | Successful pregnancy following bone marrow transplantation for leukaemia. | 1990 | 13 |
| 4 | 1989 | 44 | |
| 5 | 1989 | 28 | |
| 6 | The use of melphalan in conjunction with total body irradiation as treatment for acute leukaemia. | 1989 | 7 |
| 7 | 1988 | 10 | |
| 8 | Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. | 1988 | 57 |
| 9 | 1987 | 1 | |
| 10 | 1987 | 191 | |
| 11 | 1987 | 39 |
About A Nandi
A Nandi is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Cell Biology and Dermatology, having authored 11 papers that have together received 397 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Cancer Treatment and Pharmacology (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Cancer therapeutics and mechanisms (1 paper) and Fungal Plant Pathogen Control (1 paper). The work is most often cited by research in Hematology (321 citations), Oncology (169 citations), Genetics (47 citations), Pathology and Forensic Medicine (49 citations) and Molecular Biology (157 citations). A Nandi has collaborated with scholars based in United Kingdom and India. Frequent co-authors include Timothy Perren, Richard J. Osborne, Raymond Powles, Peter J. Selby, J. S. Malpas, M L Slevin, C R Tillyer, Garry Forgeson, S Milan and A. Zuiable. Their work appears in journals such as British Journal of Haematology, British Journal of Cancer, The Lancet, Cancer Chemotherapy and Pharmacology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.